Artiva Biotherapeutics Ownership | Who Owns Artiva Biotherapeutics?
Artiva Biotherapeutics Ownership Summary
Artiva Biotherapeutics is owned by 75.90% institutional investors, 19.88% insiders, and 4.23% retail investors. Ra capital management is the largest institutional shareholder, holding 40.42% of ARTV shares.
ARTV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Artiva Biotherapeutics | 75.90% | 19.88% | 4.23% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 9.85M | 40.42% | $14.88M |
| Vr adviser | 1.61M | 6.60% | $2.43M |
| Venbio partners | 1.15M | 4.71% | $1.73M |
| Blackrock funding, inc. /de | 485.73K | 1.99% | $733.45K |
| Samsara biocapital | 291.67K | 1.20% | $440.42K |
| Alyeska investment group | 100.00K | 0.41% | $151.00K |
| Hrt financial lp | 77.66K | 0.32% | $117.00K |
| Marshall wace, llp | 52.21K | 0.21% | $78.84K |
| Acuta capital partners | 45.46K | 0.19% | $68.64K |
| Qube research | 38.69K | 0.16% | $58.42K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Venbio partners | 1.15M | 1.51% | $1.73M |
| Ra capital management | 9.85M | 0.25% | $14.88M |
| Vr adviser | 1.61M | 0.18% | $2.43M |
| Acuta capital partners | 45.46K | 0.10% | $68.64K |
| Samsara biocapital | 291.67K | 0.09% | $440.42K |
| Y-intercept (hong kong) | 31.57K | 0.00% | $47.67K |
| Hrt financial lp | 77.66K | 0.00% | $117.00K |
| Alyeska investment group | 100.00K | 0.00% | $151.00K |
| Mark sheptoff financial planning | 400.00 | 0.00% | $604.00 |
| Qube research | 38.69K | 0.00% | $58.42K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Hrt financial lp | 77.66K | 0.00% | 77.66K |
| Marshall wace, llp | 52.21K | 0.00% | 52.21K |
| Qube research | 38.69K | 0.00% | 38.69K |
| Y-intercept (hong kong) | 31.57K | 0.00% | 31.57K |
| Mirae asset global investments | 941.00 | - | 128.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -866.62K |
| Blackrock funding, inc. /de | 485.73K | - | -759.78K |
| Rtw investments, lp | - | - | -148.84K |
| Logos global management lp | - | - | -145.09K |
| Cormorant asset management, lp | - | - | -103.63K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hrt financial lp | 77.66K | 0.00% | 77.66K | $117.00K |
| Marshall wace, llp | 52.21K | 0.00% | 52.21K | $78.84K |
| Qube research | 38.69K | 0.00% | 38.69K | $58.42K |
| Y-intercept (hong kong) | 31.57K | 0.00% | 31.57K | $47.67K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -15.00 |
| Sterling capital management | -158.00 |
| Cwm | -185.00 |
| Nelson, van denburg & campbell wealth management group | -224.00 |
| Amalgamated bank | -480.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 46 | -13.21% | 18,502,865 | -11.55% | 75 | 1.03% | 20 | -23.08% | 15 | 25.00% |
| Mar 31, 2025 | 53 | -7.02% | 20,919,893 | -1.14% | 185 | 0.53% | 26 | -7.14% | 12 | 100.00% |
| Dec 31, 2024 | 57 | 18.75% | 21,161,524 | 2.23% | 187 | 1.57% | 28 | -41.67% | 6 | - |
| Sep 30, 2024 | 48 | - | 20,699,707 | - | 109 | - | 48 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 15, 2025 | Aslan Fred | President and CEO | Sell | $69.58K |
| Jul 22, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | $91.74M | |
| Jul 22, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | $8.26M | |
| Jul 22, 2024 | 5AM Partners VI, LLC | - | Buy | $10.00M |
| Jul 22, 2024 | venBio Global Strategic Fund III, L.P. | - | Buy | $5.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 8 | - |
ARTV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools